receives

MatchMove Receives Frost & Sullivan’s 2025 Singapore Enabling Technology Leadership Recognition for Excellence in Embedded Finance Innovation

Recognition underscores MatchMove's leadership in delivering cutting-edge embedded finance solutions that accelerate digital transformation through API-driven integration, AI, and scalable…

2 weeks ago

TP Receives Frost & Sullivan’s 2025 North American Company of the Year Recognition for Excellence in Secure Innovation

Frost & Sullivan recognizes TP's AI-powered cybersecurity innovation, market leadership, and customer trust in safeguarding digital customer experiences across high-risk sectors.…

2 weeks ago

Ultragenyx Receives Complete Response Letter from FDA for UX111 AAV Gene Therapy to Treat Sanfilippo Syndrome Type A (MPS IIIA)

July 11, 2025 16:30 ET  | Source: Ultragenyx Pharmaceutical Inc. Complete Response Letter (CRL) cited specific chemistry, manufacturing and controls…

2 weeks ago

AeC Receives Frost & Sullivan’s 2025 Brazilian Company of the Year Award for Excellence in Customer Experience Management

The company is recognized for innovation, operational excellence, and customer-centric digital transformation in Brazil's fast-evolving CXM landscape SAN ANTONIO, July…

2 weeks ago

Drger Receives Frost & Sullivan’s 2025 Global Company of the Year Recognition for Excellence in Respiratory Devices Innovation

Dräger recognized for pioneering innovations in respiratory care, delivering measurable improvements in patient outcomes, clinical efficiency, cost-effectiveness and critical care…

2 weeks ago

Gozellix Receives Permanent HCPCS Code

MELBOURNE, Australia and INDIANAPOLIS, July 10, 2025 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, “Telix”) today announces…

2 weeks ago

Rainbow Productions receives the Kings Award for Enterprise

Tuesday 6 May, 2025 Not for publication before 1 AM on the 6th of May 2025 Rainbow Productions receives the…

3 weeks ago

HOTEL101 GLOBAL RECEIVES APPROVAL TO LIST ON NASDAQ UNDER “HBNB”

Celebrated Public Listing by Ringing the Opening Bell Today at the Nasdaq Stock Exchange SINGAPORE, June 28, 2025 /PRNewswire/ -- Hotel101…

3 weeks ago

AB Science: Masitinib receives FDA and EMA authorization for confirmatory phase 3 trial in metastatic castrate-resistant prostate cancer

PRESS RELEASE MASITINIB RECEIVES FDA AND EMA AUTHORIZATION FOR CONFIRMATORY PHASE 3 TRIAL IN METASTATIC CASTRATE-RESISTANT PROSTATE CANCER, WITH BIOMARKER-DRIVEN…

3 weeks ago

ReCerf Receives its CE Mark, Advancing Access to Ceramic Hip Resurfacing Across Europe

LEATHERHEAD, England, July 3, 2025 /PRNewswire/ -- MatOrtho® is proud to announce that the ReCerf® Hip Resurfacing Arthroplasty (HRA) has…

3 weeks ago